Group 1 innate lymphocytes consist of a phenotypically, spatially, and functionally heterogeneous population of NK cells and ILC1s that are engaged during pathogen invasion. We are only beginning to understand the context-dependent roles that different subsets of group 1 innate lymphocytes play during homeostatic perturbations.
| INTRODUC TI ON
The founding member of the innate lymphoid cell (ILC) family, the natural killer (NK) cell, was first described in 1975 as a cytotoxic lymphocyte capable of killing tumor cells without prior sensitization. [1] [2] [3] [4] We now appreciate that circulating natural killer cells ("cytotoxic" ILCs) sit among a diverse family of non-cytotoxic helper lymphocytes ("helper" ILCs) that similarly lack expression of a somatically rearranged antigen receptor (extensively reviewed in 5, 6) . Thus, ILCs have not been generally described to exhibit antigen specificity. Their localization and long-term tissue residency primarily at barrier surfaces uniquely position ILCs to respond as "sentinels" to endogenous factors that signify homeostatic perturbations, including, but not limited to, cytokines, alarmins, lipid mediators, and hormones. 5, 6 Given similar transcriptional requirements for development and similar effector cytokine profiles shared between subsets of ILCs and helper T cells, the ILC family has been divided into three distinct groups: group 1 ILCs, group 2 ILCs, and group 3 ILCs, that mirror adaptive T H 1, T H 2, and T H 17 cells, respectively. 7 This review will focus on group 1 ILCs, composed of NK cells and ILC1s, which similarly require and constitutively express the transcription factor T-bet, rely on IL-15 signaling for their development, and produce interferon (IFN)-γ in response to interleukin (IL)-12. have concluded that ILCs are dispensable in the presence of adaptive lymphocytes. 9 Perhaps evolution has engineered redundancy into the immune system to ensure effective immunity, and ILCs may indeed serve an important "spare tire" function during states of adaptive lymphocyte deficiency or dysfunction. However, there is evidence to support that some ILC subsets were already present alongside the prototypic adaptive lymphocytes in the most basal vertebrates, 10 implying an evolutionarily important functional role for ILCs. Consistent with this, a growing body of literature supports an essential yet context-dependent role for ILCs in immunity, 11 suggesting their function may be more nuanced than previously appreciated. In this review, we consider group 1 ILC responses to viral infection. We discuss the regulation and function of group 1 ILCs in the context of myeloid cell and adaptive lymphocyte responses, with a focus on how the unique properties of ILC1s and NK cells endow these cells with spatially and temporally distinct, yet critical roles in viral control.
| PROPERTIE S OF NK CELL S AND ILC1S
The first evidence for the existence of a non-NK cell, IFN-γ-producing innate lymphocyte stemmed from the identification of a thymic NKp46 + cell population in mice that possesses greater capacity for IFN-γ production but reduced cytotoxicity compared with splenic NK cells. 12 However, shared expression of the conventional activating NK cell receptors NKp46 and NK1.1 by thymic and splenic NK cells led to the proposal that these populations represented stages on the developmental continuum toward NK cell functionality in mice, 12 comparable to CD56 lo and CD56 hi NK cell subsets in human blood. 13 Nevertheless, growing evidence supports the hypothesis that NK cells and ILC1s are actually distinct, stable cell lineages, and can be differentiated on the basis of their developmental origin, transcriptional dependencies, phenotype, tissue residency status, and localization ( Figure 1 ). We will explore each of these properties sequentially.
| Development and transcriptional regulation
All mouse ILCs originate from the common lymphoid progenitor (CLP), as well as downstream multipotent progenitors, the α-lymphoid progenitor (αLP) and the early innate lymphoid progenitor (EILP), which lack the potential to differentiate into adaptive lymphocytes. 14 However, NK cell developmental potential is lost as were maintained during MCMV infection. 28 However, two groups recently reported that transforming growth factor (TGF)-β signaling regulates the conversion of NK cells into ILC1-like cells in the tumor microenvironment, 35, 36 suggesting that the stability of the NK cell and ILC1 lineages may indeed be context-dependent. 
| Tissue residency and localization

| IMMUNIT Y TO CMV: A HIS TORI C AL PER S PEC TIVE
Cytomegalovirus (CMV) is a β-herpes virus with broad tissue tropism. It is a common congenital and opportunistic infection, which can lead to serious complications or death, yet does not cause any life-threatening disease in healthy individuals. 50 The initial isolation of MCMV and the characterization of its infection in mice have led the field to adopt it as a powerful tool to study the endogenous immune response to virus. 51 Furthermore, MCMV shares common features with human cytomegalovirus (HCMV), including its evasion strategies, tissue tropism, disease progression, latency, recurrence following immunosuppression, and control by similar immune cells, thus providing a useful model of human disease. 52, 53 Adoptive transfer and depletion experiments in mice elucidated that control of MCMV infection is dependent on NK cells. [54] [55] [56] Careful genetic studies comparing C57BL/6 (resistant to MCMV) and BALB/c (susceptible to MCMV) strains of mice led to the identification of Cmv1 as the crucial MCMV resistance gene, 57 which was later mapped to the NK gene cluster (NKC) on chromosome 6 that encodes an array of activating and inhibitory NK cell receptors. ter. [64] [65] [66] More recently, the receptor-ligand interaction mediating human NK cell recognition of HCMV-infected cells was identified.
HCMV-encoded UL40 peptides loaded onto the non-classical MHC class I molecule HLA-E on infected cells 67 were shown to activate human NK cells expressing the activating receptor NKG2C in a peptide-specific manner. 68 These studies altogether put forth overwhelming evidence that NK cells are indispensable for CMV control in mice and humans.
Given our relatively recent understanding of the heterogeneity within NK1. for IFN-γ production by ILC1s in conferring host protection against MCMV in the liver, and more generally, against viruses at the initial sites of viral infection. 28 We will next explore where these group 1 ILC responses fit within the broader network of innate and adaptive antiviral responses, and how they are regulated. 84 In contrast, IL-18-deficient mice, were found to survive an MCMV challenge. 84 Moreover, mice rendered unresponsive to type 1 IFN signaling were highly susceptible to MCMV infection. 88 The action of these cytokines in regulating the waves of group 1 ILC and T-cell responses that follow are the subject of the next sections.
| WAVE S OF ANTIVIR
| Second antiviral wave: ILC1s
Myeloid-derived proinflammatory cytokines initiate a second an- As discussed previously, tissue-resident cDC1s are the primary source of IL-12 in infected tissue as early as 12 hours after MCMV infection, and hepatic ILC1 IFN-γ production critically requires these IRF8-dependent cDC1s and IL-12 signaling. 28 
| Third antiviral wave: NK cells
During MCMV infection, the early wave of antiviral defense mediated by ILC1-derived IFN-γ is followed by NK cells and their IFN-γ, 101 collectively suggesting that the Ly49H + NK cell proliferative response is highly specific to the high-affinity interaction between Ly49H and the MCMV glycoprotein m157 described earlier. 62, 63 Indeed, this interaction has been reported to drive up to a 1000-fold increase in Ly49H + NK cell numbers following MCMV infection, 102 Epigenetic changes also occur in human NK cells activated by HCMV infection. [125] [126] [127] Data are presented as the mean ± SEM lymphoid and non-lymphoid tissues several months after primary MCMV infection. 
| Fourth antiviral wave: T cells
It is important to note that the epitope-specific T-cell responses that develop against MCMV infection are intricately linked to the preceding NK cell responses by way of a long-standing evolutionary struggle between CMV and the host immune system, both in mouse and human. CMV has evolved multiple immune evasion mechanisms to avoid detection by host CD8 + T cells, interfering at many levels with MHC class I presentation. 53 However, lack of self-MHC-I expression ("missing self") in the presence of activating stimuli triggers NK cell cytotoxicity. 133 It follows that the role for CD8 + T cell responses in immunity to CMV is highly dependent on the genetic makeup of the host. 107 In resistant C57BL/6 mice, which develop a Ly49H + NK cell response, the CD8 + T cell response to MCMV is dominated by multiple antigen specificities, spanning four distinct kinetic patterns. 135 The response to some epitopes follow the classical pattern of expansion, contraction, and stable memory formation, while other epitope-specific CD8 + T cells do not contract and are maintained at uncharacteristically high numbers over time ("memory inflation"). 135 Consistent with these large populations of MCMV-specific memory CD8 + T cells, adaptive lymphocyte-deficient C57BL/6 SCID and RAG1-deficient mice succumb to MCMV several weeks after infection, supporting a role for T cells in late suppression of viremia. 136 Indeed, T cells have been shown to control MCMV infection via both perforin-and IFN-γ-mediated effector mechanisms, reviewed in ref [137] . Furthermore, the action of CD4 + T cell-derived IFN-γ on non-hematopoietic cells in the salivary gland is required to curb viral replication and shedding of MCMV by this tissue. 138, 139 Thus, even in the presence of an early ILC1 response and an MCMV-specific NK cell response, CD8 + and CD4 + T cells still serve an important protective role.
In a variety of viral infection models, NK cells shape antiviral Tcell responses at many stages. 98, 99 At the level of the T-cell priming by dendritic cells, NK cell-mediated target cell killing modulates the antigenic load, 140 and NK cell-derived IFN-γ production both induces T-helper cell type 1 (T H 1) polarization, 141 and regulates dendritic cell and T-cell recruitment. 142 Sustained secretion of IL- 145 Although CD4 + T cell depletion prolongs the duration of infection, it was found to coincide with less Sjogren's syndrome-like autoimmunity, 145 suggesting that NK cells may function as rheostats to balance robust T-cell antiviral responses with the potential for developing autoimmunity.
| CON CLUS I ON S AND FUTURE DIREC TIONS
Although there is still much work to be done, we now understand many details of the molecular and cellular players mediating antiviral immunity. However, how temporally and spatially distinct waves of immune responses are integrated at the organismal level is a field in its infancy. 150 Using MCMV infection as a model, we have herein 
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